Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terlipressin Bolus Versus Continuous Infusion in Patients With Variceal Hemorrhage

NCT04028505 is registered in ClinicalTrials.gov with Aga Khan University as lead sponsor.

NCT NCT04028505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04028505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terlipressin Bolus Versus Continuous Infusion in Patients With Variceal Hemorrhage
Lead sponsor
Aga Khan University
Phase
Phase 3
Overall status
Unknown status
Start date
October 25, 2018
Completion date
October 25, 2020
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

terlipressin adverse reaction